Institutional Ownership Global Blood Therapeutics, Inc. (GBT)
This table provides information about the institutional ownership of Global Blood Therapeutics, Inc. (GBT). We have compiled data on the 8 institutions that hold shares in the stock, with a total of 287,966 shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Roosevelt Investment Group LLC
|
Oct 19, 2022 Q3 2022 |
146,845
shares
|
$0
0.72% of portfolio
|
Q3 2022
Reduced 81.7%
|
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
46,344
shares
|
$0
0.03% of portfolio
|
Q3 2022
Added 233.46%
|
|
|
S. Muoio & Co. LLC
New York, NY |
Nov 14, 2022 Q3 2022 |
40,710
shares
|
$0
3.66% of portfolio
|
Q3 2022
New holding
|
|
|
Taylor Wealth Management Partners
Boston, MA |
Aug 12, 2022 Q2 2022 |
27,917
shares
|
$0
0.51% of portfolio
|
Q2 2022
Reduced 5.73%
|
|
|
Sarissa Consulting LLC
Santa Monica, CA |
Nov 14, 2022 Q3 2022 |
26,000
shares
|
$0
1.83% of portfolio
|
Q3 2022
New holding
|
|
|
Wipfli Financial Advisors Llc,
|
Oct 26, 2022 Q3 2022 |
145
shares
|
$0
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Siena Capital LLC
Cincinnati, OH |
Nov 02, 2022 Q3 2022 |
4
shares
|
$0
0.0% of portfolio
|
Q2 2022
Reduced 84.0%
|
|
|
Huntington National Bank
Columbus, OH |
Nov 06, 2024 Q3 2024 |
1
shares
|
$0
0.0% of portfolio
|
Q4 2022
Reduced 99.55%
|